Related Experiment Video
Updated: Jul 24, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
[Autoimmune glial fibrillary acidic protein astrocytopathy with posterior column ataxia: two case reports]
Ko Hiyama1, Tatsuya Ueno1, Maki Miura1
1Department of Neurology, Aomori prefectural Central Hospital.
Abstract:
The patients were a 59-year-old man and a 53-year-old woman, both of whom had preceding fever, followed by impaired consciousness, urinary retention, and unsteadiness while standing. Neurological examination revealed truncal ataxia. Cerebrospinal fluid testing was positive for anti-glial fibrillary acidic protein (GFAP) α antibodies, leading to a diagnosis of GFAP astrocytopathy. Both patients showed improvement following steroid therapy. Somatosensory evoked potential (SEP) in the tibial nerve stimulation demonstrated prolonged N21-P38 conduction times in both cases, suggesting involvement of the posterior columns of the spinal cord. These findings indicate that posterior column dysfunction may contribute to ataxia in GFAP astrocytopathy, and that SEPs may be a useful diagnostic tool for lesion localization in this condition.
More Related Videos
09:36Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis
Published on: June 23, 2022
06:02Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants
Published on: November 28, 2025
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis ll: Pathophysiology